Christoph Samuel Ziegler Insider Trades & Stock Holdings

Director · Veraxa Biotech AG - Post de-SPAC · Latest filing Oct 20, 2026

Christoph Samuel Ziegler, Director at Veraxa Biotech AG - Post de-SPAC has 1 Form 4 trade on file since Oct 20, 2026. Open-market activity: 1 purchase ($32.70K) and 0 sales ($0), net +$32.70K. Latest filing: acquired 30K shares of $VRXA on Oct 20, 2026 at $1.09.

Trades on file

1

Open-market bought

$32.70K

Open-market sold

$0

Net open-market

+$32.70K

Shares held ($VRXA)

37.93K

Latest filing

Oct 20, 2026

Shares held by Christoph Samuel Ziegler

• $VRXA37.93K sh

Shares owned after the most recent Form 4 for each company.

All insider trades by Christoph Samuel Ziegler

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 20, 2026	$VRXA	Buy (Open-market buy)	30K	$1.09	$32.70K	37.93K	+378.21%				Director	SEC	Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Christoph Samuel Ziegler traded

• $VRXA

Frequently asked questions

Has Christoph Samuel Ziegler been buying or selling stock?

Christoph Samuel Ziegler has 1 open-market purchase and 0 open-market sales on file, net +$32.70K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Christoph Samuel Ziegler's latest insider trade?

acquired 30K shares of $VRXA on Oct 20, 2026 at $1.09.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.